Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Journal:
Current Gene Therapy
Volume:
4
Page:
297-308
Author(s):
S. Indraccolo
Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Journal:
Current Pharmacogenomics
Volume:
2
Page:
243-254
Author(s):
Diane Downie, Patrick H. Rooney, Morag C.E. McFadyen and Graeme I. Murray
AKT: A Potential Target for Thyroid Cancer Therapy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
181-185
Author(s):
Faiza Kada, Motoyasu Saji and Matthew D. Ringel
Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
253-256
Author(s):
M. A. Zeiger and A. K. Meeker
Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
445-447
Author(s):
Edward A. Sausville
Recent Applications of RNAi in Mammalian Systems
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
355-360
Author(s):
Lisa Scherer and John J. Rossi
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
Ribozymes in the Age of Molecular Therapeutics
Journal:
Current Molecular Medicine
Volume:
4
Page:
489-506
Author(s):
Sepideh Bagheri and Mohammed Kashani-Sabet
Silencing of Disease-related Genes by Small Interfering RNAs
Journal:
Current Molecular Medicine
Volume:
4
Page:
507-517
Author(s):
U. Fuchs, C. Damm-Welk and A. Borkhardt
Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2535-2555
Author(s):
M. Driel van, H. A.P. Pols and J.P. T.M. van Leeuwen